Stocktoria
MBX Biosciences, Inc. MBX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-09-13
MBX Biosciences, Inc. statistics & valuation
Market cap$2.5B
P / B6.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -22.6% | -23.1% | -38.7% |
| Return on equity | -23.6% | -24.1% | 44.9% |
| Current ratio | 24.62 | 24.19 | 21.26 |
Source: SEC EDGAR filings · CIK 0001776111 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.